Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Assessment and Treatment of Nonadherence in Transplant Recipients.

Shneider C, Dunphy C, Shemesh E, Annunziato RA.

Gastroenterol Clin North Am. 2018 Dec;47(4):939-948. doi: 10.1016/j.gtc.2018.07.015. Epub 2018 Sep 28. Review.

PMID:
30337042
2.

Neurologic provider views on patient-reported outcomes including depression screening.

Katzan IL, Thompson NR, Dunphy C, Urchek J, Lapin B.

Neurol Clin Pract. 2018 Apr;8(2):86-92. doi: 10.1212/CPJ.0000000000000438.

PMID:
29708224
3.

Evaluation of a rehabilitation planning consult for survivors of head and neck cancer.

McEwen SE, Dunphy C, Rios JN, Davis AM, Jones J, Martino R, Poon I, Ringash J.

Head Neck. 2018 Jul;40(7):1415-1424. doi: 10.1002/hed.25113. Epub 2018 Mar 22.

PMID:
29566448
4.

A systematic review of immunosuppressant adherence interventions in transplant recipients: Decoding the streetlight effect.

Duncan S, Annunziato RA, Dunphy C, LaPointe Rudow D, Shneider BL, Shemesh E.

Pediatr Transplant. 2018 Feb;22(1). doi: 10.1111/petr.13086. Epub 2017 Dec 7. Review.

PMID:
29218760
5.

Head and Neck Cancer Survivorship: Learning the Needs, Meeting the Needs.

Ringash J, Bernstein LJ, Devins G, Dunphy C, Giuliani M, Martino R, McEwen S.

Semin Radiat Oncol. 2018 Jan;28(1):64-74. doi: 10.1016/j.semradonc.2017.08.008. Review.

PMID:
29173757
6.

Development and pre-testing of a rehabilitation planning consultation for head-and-neck cancer.

McEwen S, Dunphy C, Norman Rios J, Davis A, Jones J, Lam A, Poon I, Martino R, Ringash J.

Curr Oncol. 2017 Jun;24(3):153-160. doi: 10.3747/co.24.3529. Epub 2017 Jun 27.

7.

Patient Satisfaction with Collection of Patient-Reported Outcome Measures in Routine Care.

Recinos PF, Dunphy CJ, Thompson N, Schuschu J, Urchek JL 3rd, Katzan IL.

Adv Ther. 2017 Feb;34(2):452-465. doi: 10.1007/s12325-016-0463-x. Epub 2016 Dec 20.

PMID:
28000165
8.

Contralateral pelvic drop during gait increases knee adduction moments of asymptomatic individuals.

Dunphy C, Casey S, Lomond A, Rutherford D.

Hum Mov Sci. 2016 Oct;49:27-35. doi: 10.1016/j.humov.2016.05.008. Epub 2016 Jun 7.

PMID:
27286307
9.

"I didn't actually know there was such a thing as rehab": survivor, family, and clinician perceptions of rehabilitation following treatment for head and neck cancer.

McEwen S, Rodriguez AM, Martino R, Poon I, Dunphy C, Rios JN, Ringash J.

Support Care Cancer. 2016 Apr;24(4):1449-53. doi: 10.1007/s00520-015-3021-1. Epub 2015 Nov 18.

PMID:
26576966
10.

The Challenges of Data Quality Evaluation in a Joint Data Warehouse.

Bae CJ, Griffith S, Fan Y, Dunphy C, Thompson N, Urchek J, Parchman A, Katzan IL.

EGEMS (Wash DC). 2015 May 22;3(1):1125. doi: 10.13063/2327-9214.1125. eCollection 2015.

11.

Contemporary review of the 532 nm laser for treatment of benign prostatic hyperplasia.

Chughtai B, Laor L, Dunphy C, Te A.

Asian J Urol. 2015 Apr;2(2):102-106. doi: 10.1016/j.ajur.2015.04.021. Epub 2015 Apr 16. Review.

12.

Effect of phosphodiesterase inhibitors in the bladder.

Chughtai B, Ali A, Dunphy C, Kaplan SA.

Asian J Urol. 2015 Jan;2(1):33-37. doi: 10.1016/j.ajur.2015.04.014. Epub 2015 Apr 16. Review.

13.

Diagnosis, Evaluation, and Treatment of Mixed Urinary Incontinence in Women.

Chughtai B, Laor L, Dunphy C, Lee R, Te A, Kaplan S.

Rev Urol. 2015;17(2):78-83. doi: 10.3909/riu0653.

14.

Relationship Between Depression and Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Dunphy C, Laor L, Te A, Kaplan S, Chughtai B.

Rev Urol. 2015;17(2):51-7. doi: 10.3909/riu0658.

15.

Pathologic Outcomes following Urethral Diverticulectomy in Women.

Laudano MA, Jamzadeh AE, Dunphy C, Lee RK, Robinson BD, Tyagi R, Kaplan SA, Te AE, Chughtai B.

Adv Urol. 2014;2014:861940. doi: 10.1155/2014/861940. Epub 2014 Apr 17.

17.

The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.

Zhang J, Jima D, Moffitt AB, Liu Q, Czader M, Hsi ED, Fedoriw Y, Dunphy CH, Richards KL, Gill JI, Sun Z, Love C, Scotland P, Lock E, Levy S, Hsu DS, Dunson D, Dave SS.

Blood. 2014 May 8;123(19):2988-96. doi: 10.1182/blood-2013-07-517177. Epub 2014 Mar 28.

18.

Atypical Epstein-Barr viral genomic structure in lymphoma tissue and lymphoid cell lines.

Tang W, Fan H, Schroeder J, Dunphy CH, Bryant RJ, Fedoriw Y, Gulley ML.

Diagn Mol Pathol. 2013 Jun;22(2):91-101. doi: 10.1097/PDM.0b013e318273fb43.

19.

Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature.

Alley CL, Wang E, Dunphy CH, Gong JZ, Lu CM, Boswell EL, Burchette J, Lagoo AS.

Arch Pathol Lab Med. 2013 Apr;137(4):503-17. doi: 10.5858/arpa.2011-0696-OA. Review.

PMID:
23544940
20.

Introduction to the series of reactive and abnormal lymphoid proliferations mimicking malignant lymphoma.

Dunphy CH, Ferry JA.

Semin Diagn Pathol. 2013 May;30(2):101. doi: 10.1053/j.semdp.2012.08.004. Epub 2013 Mar 26. No abstract available.

PMID:
23541275
21.

Immunosuppressive and immunomodulatory therapy-associated lymphoproliferative disorders.

Bagg A, Dunphy CH.

Semin Diagn Pathol. 2013 May;30(2):102-12. doi: 10.1053/j.semdp.2012.08.005. Epub 2013 Mar 26. Review.

PMID:
23541274
22.

Diagnostic complexities of eosinophilia.

Montgomery ND, Dunphy CH, Mooberry M, Laramore A, Foster MC, Park SI, Fedoriw YD.

Arch Pathol Lab Med. 2013 Feb;137(2):259-69. doi: 10.5858/arpa.2011-0597-RA. Review.

PMID:
23368869
23.

Genetic heterogeneity of diffuse large B-cell lymphoma.

Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C, Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A, Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J, Chadburn A, Levy S, Dunson D, Dave SS.

Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1398-403. doi: 10.1073/pnas.1205299110. Epub 2013 Jan 4.

24.

The genetic landscape of mutations in Burkitt lymphoma.

Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WW, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS.

Nat Genet. 2012 Dec;44(12):1321-5. doi: 10.1038/ng.2468. Epub 2012 Nov 11.

25.

Complete spontaneous remission of diffuse large B-cell lymphoma of the maxillary sinus after concurrent infections.

Buckner TW, Dunphy C, Fedoriw YD, van Deventer HW, Foster MC, Richards KL, Park SI.

Clin Lymphoma Myeloma Leuk. 2012 Dec;12(6):455-8. doi: 10.1016/j.clml.2012.06.007. Epub 2012 Sep 29. No abstract available.

PMID:
23025990
26.

Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study.

Hoeller S, Zhou Y, Kanagal-Shamanna R, Xu-Monette ZY, Hoehn D, Bihl M, Swerdlow SH, Rosenwald A, Ott G, Said J, Dunphy CH, Bueso-Ramos CE, Lin P, Wang M, Miranda RN, Tzankov A, Medeiros LJ, Young KH.

Hum Pathol. 2013 Jan;44(1):110-21. doi: 10.1016/j.humpath.2012.04.022. Epub 2012 Aug 31. Review.

27.

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.

Visco C, Tzankov A, Xu-Monette ZY, Miranda RN, Tai YC, Li Y, Liu WM, d'Amore ES, Li Y, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, Zu Y, Bhagat G, Wang HY, Dunphy CH, His ED, Zhao XF, Choi WW, Zhao X, van Krieken JH, Huang Q, Ai W, O'Neill S, Ponzoni M, Ferreri AJ, Kahl BS, Winter JN, Go RS, Dirnhofer S, Piris MA, Møller MB, Wu L, Medeiros LJ, Young KH.

Haematologica. 2013 Feb;98(2):255-63. doi: 10.3324/haematol.2012.066209. Epub 2012 Aug 28.

28.

Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD development.

Fedoriw Y, Samulski TD, Deal AM, Dunphy CH, Sharf A, Shea TC, Serody JS, Sarantopoulos S.

Biol Blood Marrow Transplant. 2012 Jun;18(6):968-73. doi: 10.1016/j.bbmt.2012.03.005. Epub 2012 Mar 20.

29.

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.

Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Li Y, Tzankov A, Wen W, Liu WM, Kahl BS, d'Amore ES, Montes-Moreno S, Dybkær K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Winter JN, Wang HY, O'Neill S, Dunphy CH, Hsi ED, Zhao XF, Go RS, Choi WW, Zhou F, Czader M, Tong J, Zhao X, van Krieken JH, Huang Q, Ai W, Etzell J, Ponzoni M, Ferreri AJ, Piris MA, Møller MB, Bueso-Ramos CE, Medeiros LJ, Wu L, Young KH.

Leukemia. 2012 Sep;26(9):2103-13. doi: 10.1038/leu.2012.83. Epub 2012 Mar 22. Erratum in: Leukemia. 2014 Apr;28(4):980.

30.

Mantle cell lymphoma as a component of composite lymphoma: clinicopathologic parameters and biologic implications.

Papathomas TG, Venizelos I, Dunphy CH, Said JW, Wang ML, Campo E, Swerdlow SH, Chan JC, Bueso-Ramos CE, Weisenburger DD, Medeiros LJ, Young KH.

Hum Pathol. 2012 Apr;43(4):467-80. doi: 10.1016/j.humpath.2011.08.024. Epub 2012 Jan 4. Review.

PMID:
22221705
31.

The Knowledge Program: an innovative, comprehensive electronic data capture system and warehouse.

Katzan I, Speck M, Dopler C, Urchek J, Bielawski K, Dunphy C, Jehi L, Bae C, Parchman A.

AMIA Annu Symp Proc. 2011;2011:683-92. Epub 2011 Oct 22.

32.

Anaplastic large cell lymphoma: an unusual presentation in a 7-year-old girl.

Ju E, Adigun C, Dunphy C, Gold S, Morrell DS.

Pediatr Dermatol. 2012 Jul-Aug;29(4):498-503. doi: 10.1111/j.1525-1470.2011.01465.x. Epub 2011 Oct 4.

PMID:
21967522
33.

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.

Montes-Moreno S, Martinez N, Sanchez-Espiridión B, Díaz Uriarte R, Rodriguez ME, Saez A, Montalbán C, Gomez G, Pisano DG, García JF, Conde E, Gonzalez-Barca E, Lopez A, Mollejo M, Grande C, Martinez MA, Dunphy C, Hsi ED, Rocque GB, Chang J, Go RS, Visco C, Xu-Monette Z, Young KH, Piris MA.

Blood. 2011 Jul 28;118(4):1034-40. doi: 10.1182/blood-2010-11-321554. Epub 2011 Jun 1.

34.

Comparative analysis of detecting monocytic cells and their aberrancy.

Dunphy CH.

Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):336-40. doi: 10.1097/PAI.0b013e3182052805.

PMID:
21293259
35.

Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.

Jima DD, Zhang J, Jacobs C, Richards KL, Dunphy CH, Choi WW, Au WY, Srivastava G, Czader MB, Rizzieri DA, Lagoo AS, Lugar PL, Mann KP, Flowers CR, Bernal-Mizrachi L, Naresh KN, Evens AM, Gordon LI, Luftig M, Friedman DR, Weinberg JB, Thompson MA, Gill JI, Liu Q, How T, Grubor V, Gao Y, Patel A, Wu H, Zhu J, Blobe GC, Lipsky PE, Chadburn A, Dave SS; Hematologic Malignancies Research Consortium.

Blood. 2010 Dec 2;116(23):e118-27. doi: 10.1182/blood-2010-05-285403. Epub 2010 Aug 23.

36.

A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression.

Chang CM, Schroeder JC, Olshan AF, Dunphy CH, Huang WY, Baric RS, Conway K, Cerhan JR, Lynch CF, Rothman N, Cantor KP, Blair A.

Cancer Causes Control. 2010 Jul;21(7):1147-54. doi: 10.1007/s10552-010-9531-8. Epub 2010 Mar 16.

37.

The implication of identifying JAK2 ( V617F ) in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis.

Olsen RJ, Dunphy CH, O'Malley DP, Rice L, Ewton AA, Chang CC.

J Hematop. 2008 Sep;1(2):111-7. doi: 10.1007/s12308-008-0014-8. Epub 2008 Aug 28.

38.

Primary mediastinal B-cell lymphoma: detection of BCL2 gene rearrangements by PCR analysis and FISH.

Dunphy CH, O'Malley DP, Cheng L, Fodrie TY, Perkins SL, Kaiser-Rogers K.

J Hematop. 2008 Sep;1(2):77-84. doi: 10.1007/s12308-008-0007-7. Epub 2008 Jun 18.

39.

Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography.

Khandani AH, Dunphy CH, Meteesatien P, Dufault DL, Ivanovic M, Shea TC.

Nucl Med Commun. 2009 Aug;30(8):594-601. doi: 10.1097/MNM.0b013e32832cc295.

PMID:
19536037
40.

Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study.

Chang CM, Schroeder JC, Huang WY, Dunphy CH, Baric RS, Olshan AF, Dorsey KC, Dent GA, Cerhan JR, Lynch CF, Rothman N, Cantor KP, Blair A.

Leuk Res. 2010 Feb;34(2):190-5. doi: 10.1016/j.leukres.2009.05.007. Epub 2009 Jun 7.

41.

Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study.

Ahmed A, Powers MP, Youker KA, Rice L, Ewton A, Dunphy CH, Chang CC.

Pathol Res Pract. 2009;205(9):634-8. doi: 10.1016/j.prp.2009.04.003. Epub 2009 May 14.

PMID:
19446406
42.

p38 mitogen-activated protein kinase has different degrees of activation in myeloproliferative disorders and myelodysplastic syndromes.

Shahjahan M, Dunphy CH, Ewton A, Zu Y, Monzon FA, Rice L, Chang CC.

Am J Clin Pathol. 2008 Oct;130(4):635-41. doi: 10.1309/2450EGK3V0XK8D9D.

PMID:
18794058
43.

The role of beta-catenin in chronic myeloproliferative disorders.

Jauregui MP, Sanchez SR, Ewton AA, Rice L, Perkins SL, Dunphy CH, Chang CC.

Hum Pathol. 2008 Oct;39(10):1454-8. doi: 10.1016/j.humpath.2008.02.007. Epub 2008 Jul 11.

PMID:
18619646
44.

Reaction patterns of TRAP and DBA.44 in hairy cell leukemia, hairy cell variant, and nodal and extranodal marginal zone B-cell lymphomas.

Dunphy CH.

Appl Immunohistochem Mol Morphol. 2008 Mar;16(2):135-9. doi: 10.1097/PAI.0b013e3180471fd4.

PMID:
18227730
45.

Usefulness of routine conventional cytogenetic analysis in tissues submitted for "lymphoma work-up".

Dunphy C, Tang W.

Leuk Lymphoma. 2008 Jan;49(1):75-80. doi: 10.1080/10428190701684500.

PMID:
18203015
46.
48.

Loss of heterozygosity identifies genetic changes in chronic myeloid disorders, including myeloproliferative disorders, myelodysplastic syndromes and chronic myelomonocytic leukemia.

O'Malley DP, Orazi A, Dunphy CH, Coleman BR, Marks RA, Wang M, Cheng L.

Mod Pathol. 2007 Nov;20(11):1166-71. Epub 2007 Aug 17.

49.

The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders.

Hsieh PP, Olsen RJ, O'Malley DP, Konoplev SN, Hussong JW, Dunphy CH, Perkins SL, Cheng L, Lin P, Chang CC.

Mod Pathol. 2007 Sep;20(9):929-35. Epub 2007 Jul 20.

50.

Grading of follicular lymphoma: comparison of routine histology with immunohistochemistry.

Martinez AE, Lin L, Dunphy CH.

Arch Pathol Lab Med. 2007 Jul;131(7):1084-8.

PMID:
17616995

Supplemental Content

Loading ...
Support Center